Leukostasis With Isolated Central Nervous System Involvement in Chronic Phase of Chronic Myelogenous Leukemia [0.03%]
慢性粒细胞白血病慢性期孤立中枢神经系统受累致 leukostasis 病例报告
Won Jin Jeon,Suhani Dalal,Jin Hyun Moon et al.
Won Jin Jeon et al.
Chronic myelogenous leukemia (CML) is a hematologic malignancy with unique significance to the field of hematology and oncology, specifically due to the development of tyrosine kinase inhibitors (TKIs). CML often presents with nonspecific s...
Case Reports
Journal of hematology. 2023 Aug;12(4):187-196. DOI:10.14740/jh1150 2023
Harnessing the Immune System: An Effective Way to Manage Diffuse Large B-Cell Lymphoma [0.03%]
利用免疫系统治疗弥漫性大B细胞淋巴瘤的有效方法
Nathan Visweshwar,Juan Felipe Rico,Robert Killeen et al.
Nathan Visweshwar et al.
Diffuse large B-cell lymphoma (DLBCL) is a heterogenous hematological disorder with malignant potential controlled by immunological characteristics of the tumor microenvironment. Rapid breakthrough in the molecular pathways has made immunol...
Hyperammonemic Encephalopathy: A Rare Presentation of Relapsed Multiple Myeloma [0.03%]
高氨血症性脑病：复发多发性骨髓瘤的罕见表现形式
Sasmith R Menakuru,Mona Atta,Nischala Ammannagari et al.
Sasmith R Menakuru et al.
Hyperammonemia is a rare cause of encephalopathy in multiple myeloma in the absence of hepatic involvement. This is the only reported case of a 74-year-old man who presented with multiple myeloma and achieved complete remission but develope...
Case Reports
Journal of hematology. 2023 Jun;12(3):128-132. DOI:10.14740/jh1097 2023
Treating Acquired Factor VIII Inhibitor and Tumor-Induced Hypoglycemia in a Case of Relapsed Diffuse Large B-Cell Lymphoma [0.03%]
1例复发弥漫大B细胞淋巴瘤并获得性凝血因子 VIII 抑制剂和肿瘤诱导性低血糖的治疗
Preston Baker,Joseph Norton,Nasheed Hossain
Preston Baker
Diffuse large B-cell lymphoma (DLCBL) is a heterogenous disease, with many phenotypic subtypes and occasional paraneoplastic syndromes being present. Herein, we describe a case of a 63-year-old woman, with relapsed/refractory DLBCL (RR-DLBC...
Case Reports
Journal of hematology. 2023 Jun;12(3):133-137. DOI:10.14740/jh1118 2023
Importance of the Third Trimester Complete Blood Count: A Case Report on Aplastic Anemia in Pregnancy [0.03%]
妊娠晚期贫血的临床价值——一个再生障碍性贫血个案报告
Jaclyn Del Pozzo,Insaf Kouba,Theodore Goldman et al.
Jaclyn Del Pozzo et al.
Aplastic anemia (AA) poses a significant threat to maternal and fetal health throughout the perinatal period. Diagnosis is based on complete blood count (CBC) and bone marrow biopsy with treatment varying based on severity of disease. This ...
Case Reports
Journal of hematology. 2023 Jun;12(3):114-117. DOI:10.14740/jh1131 2023
Real-World Data of Crizanlizumab in Sickle Cell Disease: A Single-Center Analysis [0.03%]
一项关于瑞扎纳珠单抗治疗镰状细胞病真实世界数据的单中心分析
Halle Cheplowitz,Shanna Block,Jessica Groesbeck et al.
Halle Cheplowitz et al.
Background: Crizanlizumab was approved by the United States Food and Drug Administration agency in 2019 for decreasing vaso-occlusive events (VOEs) in sickle cell disease (SCD). Data regarding the use of crizanlizumab in ...
Tyiesha Sharron Brown,Rachaita Lakra,Samip Master et al.
Tyiesha Sharron Brown et al.
Sickle cell disease is a well-known homozygous inherited hemoglobinopathy that causes vaso-occlusive phenomena and chronic hemolysis. Vaso-occlusion results in sickle cell crisis and can eventually lead to complications involving multiple o...
Case Reports
Journal of hematology. 2023 Jun;12(3):123-127. DOI:10.14740/jh958 2023
Amplification of Chromosome 1q Predicts Poor Overall Survival in Newly Diagnosed Multiple Myeloma Patients [0.03%]
染色体1q扩增预测新诊断多发性骨髓瘤患者的总生存率较差
Matevz Skerget,Barbara Skopec,Samo Zver et al.
Matevz Skerget et al.
Background: Chromosome 1q copy number alterations are common in newly diagnosed patients with multiple myeloma, and in most published studies, there is no distinction made between three copies or the addition of at least ...
Donor Cell Leukemia Following Allogeneic Hematopoietic Stem Cell Transplantation [0.03%]
异基因造血干细胞移植后移植物细胞急性白血病
Ahmed Khattab,Sunita Patruni,Gina Patrus et al.
Ahmed Khattab et al.
Approximately 25,000 allogeneic transplants are performed annually worldwide; a figure that has steadily increased over the past three decades. The study of transplant recipient survivorship has become a cogent topic and post-transplant don...
Case Reports
Journal of hematology. 2023 Jun;12(3):138-144. DOI:10.14740/jh1124 2023
An Aggressive Course of Transformed Splenic Diffuse Red Pulp Small B-Cell Lymphoma With Novel Somatic Loss-of-Function Mutation in RB1 [0.03%]
RB1新发功能丧失性突变的转化型脾红髓小B细胞淋巴瘤1例报告
Lisa-Maj Christensen,Marianne Tang Severinsen,Pragya Katoch et al.
Lisa-Maj Christensen et al.
Splenic diffuse red pulp small B-cell lymphoma (SDRPL) is an extremely rare B-cell lymphoma. The disease is typically indolent and treatment with splenectomy usually results in durable remissions. Here, we present a case of an extremely agg...
Case Reports
Journal of hematology. 2023 Jun;12(3):118-122. DOI:10.14740/jh1132 2023